Traws Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2026 | 1.20 M | $1.01 M | 98.71% | 11.31% |
| ALLY BRIDGE GROUP (NY) LLC | 08/14/2026 | 786.24 K | $663.03 K | 100.00% | 7.39% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 730.00 K | $615.61 K | 0.00% | 6.86% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 597.73 K | $504.07 K | 287.89% | 5.62% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 559.47 K | $471.80 K | 3,610.51% | 5.26% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 478.14 K | $403.22 K | -29.49% | 4.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 398.49 K | $336.04 K | 100.00% | 3.74% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 330.05 K | $278.23 K | 497.99% | 3.10% |
| JANE STREET GROUP, LLC | 08/14/2026 | 216.01 K | $182.16 K | 916.93% | 2.03% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 164.38 K | $138.62 K | 100.00% | 1.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 133.94 K | $112.95 K | -31.15% | 1.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 111.37 K | $93.92 K | 44.44% | 1.05% |
| HRT FINANCIAL LP | 08/14/2026 | 91.22 K | $76.00 K | 100.00% | 0.86% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 84.40 K | $71.18 K | 100.00% | 0.79% |
| DAUNTLESS INVESTMENT GROUP, LLC | 08/13/2026 | 80.57 K | $67.95 K | -80.68% | 0.76% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 54.51 K | $45.95 K | 71.40% | 0.51% |
| NORTHERN TRUST CORP | 08/13/2026 | 37.45 K | $31.59 K | 100.00% | 0.35% |
| STATE STREET CORP | 08/07/2026 | 25.80 K | $21.76 K | 0.00% | 0.24% |
| XTX TOPCO LTD | 08/14/2026 | 18.09 K | $15.26 K | 100.00% | 0.17% |
| SG AMERICAS SECURITIES, LLC | 08/07/2026 | 14.52 K | $12.00 K | 100.00% | 0.14% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 12.58 K | $11.00 K | 100.00% | 0.12% |
| BLACKROCK, INC. | 08/07/2026 | 9.94 K | $8.38 K | -0.15% | 0.09% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 5.14 K | $4.34 K | 29.72% | 0.05% |
| HUNTINGTON NATIONAL BANK | 08/13/2026 | 4.68 K | $3.94 K | 100.00% | 0.04% |
| UBS GROUP AG | 08/13/2026 | 3.45 K | $2.91 K | -14.85% | 0.03% |
| BARCLAYS PLC | 08/14/2026 | 1.95 K | $1.64 K | 100.00% | 0.02% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 1.72 K | $1.45 K | 1,244.53% | 0.02% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 500 | $414 | 100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 468 | $395 | -87.45% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 262 | $221 | 0.00% | 0.00% |
| CASSADAY & CO WEALTH MANAGEMENT LLC | 08/10/2026 | 6 | $6 | -45.45% | 0.00% |
| FMR LLC | 08/13/2026 | 2 | $2 | -91.30% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 2 | $2 | 0.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 2 | $2 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| PALUMBO WEALTH MANAGEMENT LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| ROBINSWOOD FINANCIAL LLC | 07/15/2026 | 0 | $0 | -100.00% | 0.00% |
Traws Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of Traws Pharma Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 1.2 M
Ally Bridge Group (NY) LLC: 786,236
ADAGE CAPITAL PARTNERS GP, L.L.C.: 730,000
ADAR1 Capital Management, LLC: 597,729
Lynx1 Capital Management LP: 559,470
Ikarian Capital, LLC: 478,142
57.86% of Traws Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.24 M shares in the last 24 months. This purchase volume represents approximately $10.43 M in transactions.